Established collaborations with prominent brands to introduce new bio-based materials that substituted plastics and animal-derived products in leather and elastomeric foam applications. Initiated and facilitated new partnerships across plant-based meats, cellular scaffolding, cosmetics, and apparel. Crafted compelling brand narratives and conveyed the value proposition of the company's biofabrication platform to target markets.

Built a novel business unit and brand, Forager, by utilizing Ecovative's technology and creating all marketing and sales materials for the business launch.

Led a team in devising and implementing brand development, customer experience enhancement, client acquisition, and market positioning strategies to drive growth within the food tech and direct-to-consumer (DTC) sectors. Defined a distinctive brand viewpoint with significant impact by gaining an in-depth understanding of the plant-based meat market and customer base.

Directed Intrexon's consumer sector expansion through advanced biologically-based solutions to form and commercialize products benefiting consumers. Developed a skilled team to execute acquisition due diligence and drive product and technology commercialization efforts.• Collaborated as an integral member of the executive management team, directly supporting the Chairman & CEO.• Advanced organizational growth and progress by overseeing research and development (R&D) activities… Show more Directed Intrexon's consumer sector expansion through advanced biologically-based solutions to form and commercialize products benefiting consumers. Developed a skilled team to execute acquisition due diligence and drive product and technology commercialization efforts.• Collaborated as an integral member of the executive management team, directly supporting the Chairman & CEO.• Advanced organizational growth and progress by overseeing research and development (R&D) activities focused on creating new products. Show less

Managed all facets of an emerging e-commerce enterprise with consumer and biotech origins, crafting business, marketing, and scientific strategies to drive global product sales. Developed a skilled team to execute acquisition due diligence and drive product and technology commercialization efforts.• Led the foundation of a consumer biotech enterprise and expanded the business from its inception to distributing products in 20+ countries, achieving revenue surpassing $5M within four… Show more Managed all facets of an emerging e-commerce enterprise with consumer and biotech origins, crafting business, marketing, and scientific strategies to drive global product sales. Developed a skilled team to execute acquisition due diligence and drive product and technology commercialization efforts.• Led the foundation of a consumer biotech enterprise and expanded the business from its inception to distributing products in 20+ countries, achieving revenue surpassing $5M within four years.• Steered end-to-end development of BioPop's inaugural product, Dino Pet, encompassing conceptualization, design, manufacturing, bioproduction, videography, and packaging.• Featured products at the Museum of Modern Art (MoMA) in NYC that enhanced brand visibility and fostered credibility in the art and design community.• Brokered the sale of the business to a leading publicly traded synthetic biology company (Intrexon) through strategic negotiation and deal structuring. Show less

Gained licenses and platform deals for genome editing tools, cell line customization services, and stem cells within the pharmaceutical, biotechnology, and academic sectors. Directed a team of sales professionals nationwide and delivered presentations on genome engineering alongside esteemed global thought leaders. Offered in-depth marketing analysis and insights to guide the formulation of commercial strategies and refine the product development portfolio.

• Specialized in gene modulation, successfully marketed and distributed high-value RNAi and Gene Expression libraries. • Achieved significant sales, including closing five transactions valued at $25k each, two transactions valued at $100k each, and securing one transaction valued at $600k, representing the largest single RNAi sale in company history.